Dr. Oliai is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
100 Medical Plaza
Suite 550
Los Angeles, CA 90095Phone+1 310-794-4955Fax+1 310-794-4955- Is this information wrong?
Education & Training
UCLA David Geffen School of Medicine/UCLA Medical CenterFellowship, Hematology and Medical Oncology, 2016 - 2019- UCLA David Geffen School of Medicine/UCLA Medical CenterResidency, Internal Medicine, 2014 - 2016
California Pacific Medical CenterResidency, Radiation Oncology, 2012 - 2016
Drexel University College of Medicine/Hahnemann University HospitalInternship, Internal Medicine, 2011 - 2012- Drexel University College of MedicineClass of 2011
Certifications & Licensure
CA State Medical License 2012 - 2024
PA State Medical License 2011 - 2012- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Medical Oncology
Clinical Trials
- Tagraxofusp to Eradicate Measurable Residual Disease in Patients With Acute Myeloid Leukemia Start of enrollment: 2024 Aug 03
- Acalabrutinib Maintenance for the Treatment of Patients With Large B-cell Lymphoma Start of enrollment: 2023 Jan 23
- Precision-T: A Randomized Study of Orca-T in Recipients Undergoing Allogeneic Transplantation for Hematologic Malignancies Start of enrollment: 2022 Jun 21
- Join now to see all
Publications & Presentations
PubMed
- Measurable residual disease conversion rate with consolidation chemotherapy in acute myeloid leukemia.Daria Gaut, Caspian Oliai, Jonathan Boiarsky, Shiliang Zhang, Amandeep Salhotra, Tali Azenkot, Vanessa E Kennedy, Vishesh Khanna, Karla Olmedo Gutierrez, Navika Shukla...> ;Leukemia & Lymphoma. 2024 Jan 1
- 2 citationsTransient SARS-CoV-2 RNA-Dependent RNA Polymerase Mutations after Remdesivir Treatment for Chronic COVID-19 in Two Transplant Recipients: Case Report and Intra-Host Vi...Shangxin Yang, Ashrit Multani, Jacob M Garrigues, Michael S Oh, Peera Hemarajata, Taylor Burleson, Nicole M Green, Caspian Oliai, Pryce T Gaynor, Omer E Beaird, Drew J...> ;Microorganisms. 2023 Aug 16
- 2 citationsPatient Characteristics and Outcomes of Outpatient Tisagenlecleucel Recipients for B Cell Non-Hodgkin Lymphoma.Ahmed, N., Wesson, W., Mushtaq, M., Porter, D., Nasta, S., Brower, J., Bachanova, V., Hu, M., Nastoupil, L., Oluwole, O., Patel, V., Oliai, C., Riedell, P., Bishop, M....> ;Transplantation and Cellular Therapy. 2023 Jul 1
- Join now to see all
Press Mentions
Orca Bio Presents Positive Data Demonstrating the Potential for Orca-T and Orca-Q to Expand Treatment to Additional Patient Groups at the 65th ASH Annual MeetingDecember 12th, 2023
Hospital Affiliations
Ronald Reagan UCLA Medical CenterLos Angeles, California
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
